DadFinStart your free weekAbrdn Life Sciences Investors (HQL) stock score
$18.15 ▲ +4.13% today
Abrdn Life Sciences Investors (HQL) is a Asset Management company in the Financial Services sector, listed in the United States. On DadFin's weekly run it scores 23.0 out of 100 on the Dad Score, a weak reading that places the business ahead of 23% of the 5,774 US and Canadian stocks DadFin fully scores. Inside Financial Services it ranks #1,050 of 1,228. Its strongest axes are valuation, risk and macro; its weakest are quality and growth.
Scores from the run of Oct 4, 2026. The Dad Score answers one question: how good is this business, measured against its own sector. How it is built →
The eight axes
Each axis is ranked inside the stock's own sector. Subscribers see the percentile and every input behind each bar.
Key numbers
What subscribers see on HQL
- Value Score: is the price right for this business, the score the Value book is selected on.
- Trader Score: is it set up to move, refreshed every 15 minutes in the session.
- The full eight-axis breakdown, every input and its percentile.
- SEC filings, insider buying, earnings history and peers side by side.
- Whether it is in this week's published books, with the receipts.
Asset Management peers
| Stock | Company | Dad Score | Band |
|---|---|---|---|
| BLK | BlackRock, Inc. | 78.8 | good |
| BX | Blackstone Inc. | 62.7 | middling |
| KKR | KKR & Co. Inc. | 14.3 | poor |
| BN | Brookfield Corporation | 17.2 | weak |
| BAM | Brookfield Asset Management Ltd. | 35.6 | weak |
| APO | Apollo Global Management, Inc. | 65.4 | middling |
| STT | State Street Corporation | 69.6 | middling |
| AMP | Ameriprise Financial, Inc. | 96.7 | strong |
Prices from DadFin's live feed (refreshed about every 15 minutes in the session); scores from the weekly run of Oct 4, 2026. Fundamentals as reported in the latest filings. Research, not investment advice.